JSE LIMITED - 20160120 Mediclinic Int Ltd Merger with Al Noor Informative Notice UPDATED

20160120 Mediclinic Int Ltd Merger with Al Noor Informative Notice UPDATED

Further to the FTSE/JSE notice released on 15 January 2016 in relation to the merger between
Mediclinic International (South Africa) and Al Noor Hospitals Group (UK) and following an update to the
scheme timetable, please see the new updated index treatment below:



       Mediclinic International Ltd (South Africa): Merger with Al Noor
            Hospitals Group (UK) - Informative Notice - Update

                                 FTSE/JSE Africa Index Series

                                           20 January 2016
Following shareholder approval and subject to the completion of the scheme of arrangement between
Mediclinic International Ltd (South Africa, ZAE000074142, B0PGJF0) and Al Noor Hospitals Group (UK,
GB00B8HX8Z88, B8HX8Z8), whereby Mediclinic International Ltd shareholders will receive 0.625 Al Noor
Hospitals Group shares for every Mediclinic International Ltd share held, FTSE/JSE is anticipating the
following index treatment in the FTSE/JSE Index Series:

Wednesday 03 February 2016 (after market close)
FTSE/JSE will issue a notice confirming all FTSE/JSE Index changes effective on both 08 February and 16
February.


Friday 05 February 2016
Last day of dealing in Mediclinic International Ltd shares.


Monday 08 February 2016 (from start of trading)
Mediclinic International Ltd (B0PGJF0) will be replaced by Al Noor Hospitals Group (BYYW9W4) in the
FTSE/JSE Indices. In order to avoid index tracking errors, the Al Noor Hospitals Group shares will be
added at the equivalent offer terms’ value to Mediclinic International’s last traded price.
There will be no index divisor change.


Monday 15 February 2016
Al Noor Hospitals Group will change its name to Mediclinic International plc.


Tuesday 16 February 2016 (from start of trading)
Mediclinic International plc will remain in the FTSE/JSE Indices. All index changes to bring Mediclinic’s
index shares in line with the JSE issued shares (as notified after market close on Wednesday 03 February
2016) will become effective.

Please note: All details are based on the current timetable.
For further information or general enquiries please contact us at info@ftse.com or indices@jse.co.za or call:

 Client Services in UK:              Tel: +44 (0) 20 7866 1810
 Client Services in EMEA:            Tel: +44 (0) 20 7866 1810
 Client Services in US:              New York: (Domestic) + 1 888 747 FTSE (3873) / (International): +1 212 314 1139
 Client Services in Asia Pacific:    Hong Kong: + 852 2164 3333 Australia:(Domestic Toll-Free) + 1800 653 680 / (International) + 61
                                     (2) 9293 2864 Japan + 81 (3) 3581 2764
 JSE Limited:                        Tel: +27 11 520 7137

Alternatively please visit our website at www.ftse.com or www.ftsejse.co.za

                                               Terms of Use | Copyright © FTSE

Date: 20/01/2016 05:08:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.